Activation of N-ras and K-ras induced by interleukin-6 in a myeloma cell line: implications for disease progression and therapeutic response
- 12 December 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (57) , 8769-8775
- https://doi.org/10.1038/sj.onc.1205387
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 20 references indexed in Scilit:
- G Proteins and Small GTPases: Distant Relatives Keep in TouchScience, 1998
- Ras-GRF Activates Ha-Ras, but Not N-Ras or K-Ras 4B, Proteinin VivoPublished by Elsevier ,1998
- Signaling mechanisms through gp130: A model of the cytokine systemCytokine & Growth Factor Reviews, 1997
- Cytochrome c-dependent and -independent Induction of Apoptosis in Multiple Myeloma CellsJournal of Biological Chemistry, 1997
- Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanismOncogene, 1997
- A Novel Technique for the Study of Ras Activity: Electroporation of [α-32P]GTPDNA and Cell Biology, 1997
- Interleukin-6 prevents dexamethasone-induced myeloma cell deathBlood, 1994
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.Journal of Clinical Investigation, 1989
- Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6Blood, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988